Sex, racial, and ethnic disparities in motor neuron disease: clinical trial enrolment
Chia-Chen Tsai Brendan Tao Madeleine Wong Haarini Suntharalingam Agessandro Abrahao Carolina Barnett-Tapia 1 Faculty of Medicine,University of British Columbia,Vancouver,BC,Canada2 Faculty of Health Sciences,Queen's University,Kingston,ON,Canada3 Division of Neurology,Department of Medicine,Sunnybrook Health Sciences Centre,University of Toronto,Toronto,ON,Canada4 Harquail Centre for Neuromodulation,Hurvitz Brain Sciences Program,Sunnybrook Research Institute,Toronto,ON,Canada5 Toronto General Hospital,Ellen and Martin Prosserman Centre for Neuromuscular Disease,Toronto,ON,Canada,and6 Division of Neurology,University of Toronto,Toronto,ON,Canada
DOI: https://doi.org/10.1080/21678421.2024.2358793
2024-06-05
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Abstract:Objective Motor neuron disease (MND) is a group of neurological diseases, the majority being amyotrophic lateral sclerosis (ALS), with varying clinical presentations across demographics. Clinical trial enrollment reflecting global disease burden improves understanding of diverse presentations and aids personalized therapy development. We assessed the sex, racial, and ethnic composition of MND/ALS clinical trial participants relative to global disease burdens.
clinical neurology